These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32950345)

  • 1. Angiotensin II and Vasoplegia in Cardiac Surgery: Paradigm Changer or Costly Contender?
    Chow JH; Strauss E; Mazzeffi MA
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):59-60. PubMed ID: 32950345
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
    Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: Is angiotensin II a game changer for vasoplegia after cardiac surgery, or is the jury still out?
    Chatterjee S
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1415-1416. PubMed ID: 33888313
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery.
    Suero OR; Park Y; Wieruszewski PM; Chatterjee S
    Crit Care Clin; 2024 Jan; 40(1):73-88. PubMed ID: 37973358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.
    Papazisi O; Palmen M; Danser AHJ
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):739-748. PubMed ID: 33085026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients.
    Chow JH; Wittwer ED; Wieruszewski PM; Khanna AK
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1407-1414. PubMed ID: 33875258
    [No Abstract]   [Full Text] [Related]  

  • 7. Power for the Sickest: Vitamin C for Vasoplegia after Cardiac Surgery.
    Long MT; Hess AS; McCarthy DP; DeCamp MM
    J Cardiothorac Vasc Anesth; 2020 Apr; 34(4):1123. PubMed ID: 31623966
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
    Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting.
    Sovic W; Mathew C; Blough B; Monday KA; Sam T; Zafar H; Guerrero-Miranda C; Sherwood M; Hebert C; Hall S; Alam A
    Methodist Debakey Cardiovasc J; 2021; 17(4):98-101. PubMed ID: 34824689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
    Nash CM
    AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery.
    Kortekaas KA; Lindeman JH; Reinders ME; Palmen M; Klautz RJ; de Groot PG; Roest M
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):523-30. PubMed ID: 23736659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Angiotensin II in Severe Vasoplegia After Left Pneumonectomy Requiring Cardiopulmonary Bypass: A Renin Response Analysis.
    Trethowan B; Michaud CJ; Fifer S
    Crit Care Med; 2020 Oct; 48(10):e912-e915. PubMed ID: 32931196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When the pressure drops: A case of vasoplegia during a structural heart intervention.
    Cox J; Noveras J; Harrell T; Nayak KR
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):280-284. PubMed ID: 31025531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery.
    Riha H; Augoustides JG
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):736-8. PubMed ID: 21684764
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
    Busse LW; Barker N; Petersen C
    Crit Care; 2020 Feb; 24(1):36. PubMed ID: 32019600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
    Gilbert M; Lema G
    Rev Med Chil; 2011 Mar; 139(3):368-72. PubMed ID: 21879171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology.
    Wieruszewski PM; Sims CR; Daly RC; Taner T; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2366-2367. PubMed ID: 31076311
    [No Abstract]   [Full Text] [Related]  

  • 18. Methylene Blue: Magic Bullet for Vasoplegia?
    Hosseinian L; Weiner M; Levin MA; Fischer GW
    Anesth Analg; 2016 Jan; 122(1):194-201. PubMed ID: 26678471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoplegia: A Review.
    Ratnani I; Ochani RK; Shaikh A; Jatoi HN
    Methodist Debakey Cardiovasc J; 2023; 19(4):38-47. PubMed ID: 37547893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.